Prevalence of documented alcohol and opioid use disorder diagnoses and treatments in a regional primary care practice-based research network.
Journal
Journal of substance abuse treatment
ISSN: 1873-6483
Titre abrégé: J Subst Abuse Treat
Pays: United States
ID NLM: 8500909
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
received:
05
04
2019
revised:
09
11
2019
accepted:
14
11
2019
entrez:
19
1
2020
pubmed:
19
1
2020
medline:
29
7
2021
Statut:
ppublish
Résumé
Most people with alcohol or opioid use disorders (AUD or OUD) are not diagnosed or treated for these conditions in primary care. This study takes a critical step toward quantifying service gaps and directing improvement efforts for AUD and OUD by using electronic health record (EHR) data from diverse primary care organizations to quantify the extent to which AUD and OUD are underdiagnosed and undertreated in primary care practices. We extracted and integrated diagnosis, medication, and behavioral health visit data from the EHRs of 21 primary care clinics within four independent healthcare organizations representing community health centers and rural hospital-associated clinics in the Pacific Northwest United States. Rates of documented AUD and OUD diagnoses, pharmacological treatments, and behavioral health visits were evaluated over a two-year period (2015-2016). Out of 47,502 adult primary care patients, 1476 (3.1%) had documented AUD; of these, 115 (7.8%) had orders for AUD medications and 271 (18.4%) had at least one documented visit with a non-physician behavioral health specialist. Only 402 (0.8%) patients had documented OUD, and of these, 107 (26.6%) received OUD medications and 119 (29.6%) had at least one documented visit with a non-physician behavioral health specialist. Rates of AUD diagnosis and AUD and OUD medications were higher in clinics that had co-located non-physician behavioral health specialists. AUD and OUD are underdiagnosed and undertreated within a sample of independent primary care organizations serving mostly rural patients. Primary care organizations likely need service models, technologies, and workforces, including non-physician behavioral health specialists, to improve capacities to diagnose and treat AUD and OUD.
Sections du résumé
BACKGROUND
Most people with alcohol or opioid use disorders (AUD or OUD) are not diagnosed or treated for these conditions in primary care. This study takes a critical step toward quantifying service gaps and directing improvement efforts for AUD and OUD by using electronic health record (EHR) data from diverse primary care organizations to quantify the extent to which AUD and OUD are underdiagnosed and undertreated in primary care practices.
METHODS
We extracted and integrated diagnosis, medication, and behavioral health visit data from the EHRs of 21 primary care clinics within four independent healthcare organizations representing community health centers and rural hospital-associated clinics in the Pacific Northwest United States. Rates of documented AUD and OUD diagnoses, pharmacological treatments, and behavioral health visits were evaluated over a two-year period (2015-2016).
RESULTS
Out of 47,502 adult primary care patients, 1476 (3.1%) had documented AUD; of these, 115 (7.8%) had orders for AUD medications and 271 (18.4%) had at least one documented visit with a non-physician behavioral health specialist. Only 402 (0.8%) patients had documented OUD, and of these, 107 (26.6%) received OUD medications and 119 (29.6%) had at least one documented visit with a non-physician behavioral health specialist. Rates of AUD diagnosis and AUD and OUD medications were higher in clinics that had co-located non-physician behavioral health specialists.
CONCLUSIONS
AUD and OUD are underdiagnosed and undertreated within a sample of independent primary care organizations serving mostly rural patients. Primary care organizations likely need service models, technologies, and workforces, including non-physician behavioral health specialists, to improve capacities to diagnose and treat AUD and OUD.
Identifiants
pubmed: 31952624
pii: S0740-5472(19)30210-7
doi: 10.1016/j.jsat.2019.11.008
pmc: PMC7255441
mid: NIHMS1546504
pii:
doi:
Substances chimiques
Analgesics, Opioid
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
18-27Subventions
Organisme : NIAAA NIH HHS
ID : K01 AA024796
Pays : United States
Organisme : NIDA NIH HHS
ID : UG1 DA013714
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002319
Pays : United States
Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.
Références
J Subst Abuse Treat. 2016 Jan;60:110-8
pubmed: 26233697
Can Fam Physician. 2015 Jun;61(6):491-3, 495-7
pubmed: 26071147
J Adolesc Health. 2004 Aug;35(2):101-7
pubmed: 15261638
Ann Intern Med. 2017 Sep 05;167(5):293-301
pubmed: 28761945
Ann Intern Med. 2016 Nov 15;165(10):690-699
pubmed: 27595276
Am J Public Health. 2013 May;103(5):774-6
pubmed: 23488498
Med Care. 2012 Oct;50(10):843-8
pubmed: 22814854
Am J Med. 2013 Jul;126(7):565-71
pubmed: 23664112
JAMA. 2014 May 14;311(18):1889-900
pubmed: 24825644
Subst Abus. 2016 Oct-Dec;37(4):625-634
pubmed: 27218678
J Behav Health Serv Res. 2017 Jul;44(3):351-363
pubmed: 28488155
Subst Abuse Rehabil. 2011 Jul 1;2011(2):125-131
pubmed: 21822398
Depress Anxiety. 2017 Jun;34(6):494-501
pubmed: 28453916
Arch Intern Med. 1998 Sep 14;158(16):1789-95
pubmed: 9738608
J Clin Psychol Med Settings. 2018 Jun;25(2):187-196
pubmed: 29234927
Am J Public Health. 2017 Feb;107(2):329-335
pubmed: 27997229
J Clin Psychol Med Settings. 2018 Jun;25(2):127-156
pubmed: 28975500
J Am Board Fam Med. 2018 Mar-Apr;31(2):243-251
pubmed: 29535241
Addict Sci Clin Pract. 2017 May 10;12(1):14
pubmed: 28490342
EGEMS (Wash DC). 2016 Mar 29;4(2):1206
pubmed: 27141519
Addiction. 2016 Dec;111(12):2079-2081
pubmed: 27412876
J Gen Intern Med. 2015 Aug;30(8):1125-32
pubmed: 25731916
Int J Environ Res Public Health. 2017 Sep 08;14(9):
pubmed: 28885557
Public Health Rev. 2014 Jan;35(2):
pubmed: 26568649
Am J Drug Alcohol Abuse. 2019;45(1):1-10
pubmed: 30675818
Fam Syst Health. 2015 Dec;33(4):330-8
pubmed: 26214008
Psychol Addict Behav. 2011 Jun;25(2):206-14
pubmed: 21517141
Ann Behav Med. 2016 Aug;50(4):533-44
pubmed: 26935310
Am J Manag Care. 2006 Oct;12(10):597-606
pubmed: 17026414
Med Care. 2012 Feb;50(2):179-87
pubmed: 20881876
Addiction. 2019 Aug;114(8):1355-1356
pubmed: 31037777
JAMA. 2014 May 14;311(18):1861-2
pubmed: 24825640
Subst Abuse Treat Prev Policy. 2013 May 30;8:17
pubmed: 23718191
Ann Fam Med. 2016 Jan-Feb;14(1):8-15
pubmed: 26755778
Drug Alcohol Depend. 2017 Oct 1;179:42-46
pubmed: 28753480
J Subst Abuse Treat. 2016 Jan;60:27-35
pubmed: 26297322
J Subst Abuse Treat. 2014 May-Jun;46(5):541-5
pubmed: 24679908
N Engl J Med. 2018 Jul 5;379(1):1-4
pubmed: 29972748
N Engl J Med. 2016 Jul 28;375(4):357-68
pubmed: 27464203
Int J Med Inform. 2016 Sep;93:26-33
pubmed: 27435944
J Gen Intern Med. 2010 Jan;25 Suppl 1:11-7
pubmed: 20077146
J Stud Alcohol Drugs. 2010 Sep;71(5):720-5
pubmed: 20731977
Ann Fam Med. 2014 Mar-Apr;12(2):128-33
pubmed: 24615308
J Subst Abuse Treat. 2018 Aug;91:57-68
pubmed: 29910015
JAMA Intern Med. 2017 Oct 1;177(10):1480-1488
pubmed: 28846769
J Addict Med. 2017 Jan/Feb;11(1):3-9
pubmed: 27610582
Drug Alcohol Depend. 2017 Sep 1;178:527-533
pubmed: 28728114
J Subst Abuse Treat. 2012 Jul;43(1):12-9
pubmed: 22154827
Drug Alcohol Depend. 2018 Jun 1;187:79-87
pubmed: 29635217
Addiction. 2019 Aug;114(8):1346-1353
pubmed: 30614096
Addict Behav. 2019 Nov;98:106010
pubmed: 31238237
JAMA. 2008 Feb 20;299(7):751-3
pubmed: 18285582
J Subst Abuse Treat. 2017 Mar;74:71-79
pubmed: 28132704
JAMA Psychiatry. 2015 Aug;72(8):757-66
pubmed: 26039070